NBI-1065845 Clinical Trials (2026): 6 Studies for Major Depressive Disorder

Where to Participate: All NBI-1065845 Trial Sites in the U.S. (88 sites across 20 states)

Every actively recruiting NBI-1065845trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

NBI-1065845 clinical trials at a glance: phase × recruitment status

Recruiting NBI-1065845 clinical trials (5)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

NBI-1065845 pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

All NBI-1065845 trials (6)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

NBI-1065845 clinical trials: frequently asked questions

How many NBI-1065845 clinical trials are there?

6 NBI-1065845 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 5 are actively recruiting participants. 1 is marked completed.

Are NBI-1065845 clinical trials recruiting in 2026?

Yes — 5 NBI-1065845 trials are actively recruiting in 2026, with 88 U.S. sites across 20 states. See the recruiting trials and the per-state site list further down this page.

What conditions is NBI-1065845 being studied for?

NBI-1065845 is being studied for Major Depressive Disorder. The trials are grouped by indication on this page.

What phase is NBI-1065845 in?

NBI-1065845 clinical trials span 5 Phase 3, 1 Phase 2. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.

Who sponsors NBI-1065845 clinical trials?

The lead sponsor across the most NBI-1065845 trials is Neurocrine Biosciences. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming NBI-1065845as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed June 18, 2026.